| Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression | |
| Chen, X; Deng, SX; Wang, WC; Castiglione, S; Duan, ZL; Luo, L; Cianci, F; Zhang, XX; Xu, JL; Li, H; Zhao, JZ; Kamau, PM; Zhang, ZY; Mwangi, J; Li, JL; Shu, YS; Hu, XT; Mazzanti, M; Lai, R | |
| 2022 | |
| 发表期刊 | MOLECULAR PSYCHIATRY
![]() |
| ISSN | 1359-4184 |
| 摘要 | As a prime mover in Alzheimer's disease (AD), microglial activation requires membrane translocation, integration, and activation of the metamorphic protein chloride intracellular channel 1 (CLIC1), which is primarily cytoplasmic under physiological conditions. However, the formation and activation mechanisms of functional CLIC1 are unknown. Here, we found that the human antimicrobial peptide (AMP) LL-37 promoted CLIC1 membrane translocation and integration. It also activates CLIC1 to cause microglial hyperactivation, neuroinflammation, and excitotoxicity. In mouse and monkey models, LL-37 caused significant pathological phenotypes linked to AD, including elevated amyloid-beta, increased neurofibrillary tangles, enhanced neuronal death and brain atrophy, enlargement of lateral ventricles, and impairment of synaptic plasticity and cognition, while Clic1 knockout and blockade of LL-37-CLIC1 interactions inhibited these phenotypes. Given AD's association with infection and that overloading AMP may exacerbate AD, this study suggests that LL-37, which is up-regulated upon infection, may be a driving force behind AD by acting as an endogenous agonist of CLIC1. |
| 收录类别 | sci |
| 语种 | 英语 |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kiz.ac.cn/handle/152453/13218 |
| 专题 | 科研部门_天然药物功能蛋白质学科组(赖仞) |
| 推荐引用方式 GB/T 7714 | Chen, X,Deng, SX,Wang, WC,et al. Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression[J]. MOLECULAR PSYCHIATRY,2022. |
| APA | Chen, X.,Deng, SX.,Wang, WC.,Castiglione, S.,Duan, ZL.,...&Lai, R.(2022).Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.MOLECULAR PSYCHIATRY. |
| MLA | Chen, X,et al."Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression".MOLECULAR PSYCHIATRY (2022). |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| 2023032107.pdf(5084KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 请求全文 | |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论